UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors

Molecular pharmacology, 2012-05, Vol.81 (5), p.643-656

2012

Volltextzugriff (PDF)

Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij rats

Neuropharmacology, 2014-10, Vol.85, p.91-103

2014

Volltextzugriff (PDF)

Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats

Neuropharmacology, 2013-03, Vol.66, p.330-338

2013

Volltextzugriff (PDF)

Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways

Journal of neurochemistry, 2001-08, Vol.78 (3), p.435-445

2001

Volltextzugriff (PDF)

Positive allosteric modulation of metabotropic glutamate 4 (mGlu4) receptors enhances spontaneous and evoked absence seizures

Neuropharmacology, 2008-02, Vol.54 (2), p.344-354

2008

Volltextzugriff (PDF)

Protective role for type-1 metabotropic glutamate receptors against spike and wave discharges in the WAG/Rij rat model of absence epilepsy

Neuropharmacology, 2011-06, Vol.60 (7), p.1281-1291

2011

Volltextzugriff (PDF)

Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus

Neuropharmacology, 2002-06, Vol.42 (8), p.1008-1015

2002

Volltextzugriff (PDF)

Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine‐induced down‐regulation of β‐adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands

Journal of neurochemistry, 2005-06, Vol.93 (5), p.1345-1352

2005

Volltextzugriff (PDF)

The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike–wave discharges in the WAG/Rij rat model of absence epilepsy

Neuropharmacology, 2005, Vol.49, p.89-103

2005

Volltextzugriff (PDF)

The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways

The European journal of neuroscience, 2001-05, Vol.13 (9), p.1694-1702

2001

Volltextzugriff (PDF)

An increased expression of the mGlu5 receptor protein following LTP induction at the perforant path–dentate gyrus synapse in freely moving rats

Neuropharmacology, 2003, Vol.44 (1), p.17-25

2003

Volltextzugriff (PDF)

P815 Diet, nutrition, and the multidisciplinary approach in adults with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i949-i950

2023

Volltextzugriff (PDF)

Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells

Journal of neurochemistry, 2003-03, Vol.84 (6), p.1288-1295

2003

Volltextzugriff (PDF)

Expression of groups I and II metabotropic glutamate receptors in the rat brain during aging

Brain research, 2005-05, Vol.1043 (1), p.95-106

2005

Volltextzugriff (PDF)

Activation of Group III Metabotropic Glutamate Receptors Inhibits the Production of RANTES in Glial Cell Cultures

The Journal of neuroscience, 2002-07, Vol.22 (13), p.5403-5411

2002

Volltextzugriff (PDF)

Reduced activity of hippocampal group-I metabotropic glutamate receptors in learning-prone rats

Neuroscience, 2003-01, Vol.122 (1), p.277-284

2003

Volltextzugriff (PDF)

Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death

European journal of pharmacology, 1998-09, Vol.356 (2), p.271-274

1998

Volltextzugriff (PDF)

Metabotropic glutamate receptors and neurodegeneration

Progress in brain research, 1998, Vol.116, p.209-221

1998

Volltextzugriff (PDF)

Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo

Neuro-oncology (Charlottesville, Va.), 2005-07, Vol.7 (3), p.236-245

2005

Volltextzugriff (PDF)

Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of [beta]-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands

Journal of neurochemistry, 2005-06, Vol.93 (5), p.1345

2005

Volltextzugriff (PDF)

Selective blockade of mGlu5 metabotropic glutamate receptors is protective against acetaminophen hepatotoxicity in mice

Journal of hepatology, 2003-02, Vol.38 (2), p.179-187

2003

Volltextzugriff (PDF)

Expression of OP4 (ORL1, NOP 1) receptors in vascular endothelium

European journal of pharmacology, 2003-12, Vol.482 (1), p.17-23

2003

Volltextzugriff (PDF)

Retracted: Neuroprotection mediated by glial group‐II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol‐3‐kinase pathways

Journal of neurochemistry, 2001-08, Vol.78 (3), p.435-445

2001

Volltextzugriff (PDF)

Bariatric Surgery and Hepatocellular Carcinoma: a Propensity Score-Matched Analysis

Obesity surgery, 2018-12, Vol.28 (12), p.3880-3889

2018

Volltextzugriff (PDF)

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts

European urology, 2021-05, Vol.79 (5), p.692-699

2021

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors

Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij rats

Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats

Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways

Positive allosteric modulation of metabotropic glutamate 4 (mGlu4) receptors enhances spontaneous and evoked absence seizures

Protective role for type-1 metabotropic glutamate receptors against spike and wave discharges in the WAG/Rij rat model of absence epilepsy

Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus

Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine‐induced down‐regulation of β‐adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands

The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike–wave discharges in the WAG/Rij rat model of absence epilepsy

The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways

An increased expression of the mGlu5 receptor protein following LTP induction at the perforant path–dentate gyrus synapse in freely moving rats

P815 Diet, nutrition, and the multidisciplinary approach in adults with Inflammatory Bowel Disease

Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells

Expression of groups I and II metabotropic glutamate receptors in the rat brain during aging

Activation of Group III Metabotropic Glutamate Receptors Inhibits the Production of RANTES in Glial Cell Cultures

Reduced activity of hippocampal group-I metabotropic glutamate receptors in learning-prone rats

Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death

Metabotropic glutamate receptors and neurodegeneration

Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo

Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of [beta]-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands

Selective blockade of mGlu5 metabotropic glutamate receptors is protective against acetaminophen hepatotoxicity in mice

Expression of OP4 (ORL1, NOP 1) receptors in vascular endothelium

Retracted: Neuroprotection mediated by glial group‐II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol‐3‐kinase pathways

Bariatric Surgery and Hepatocellular Carcinoma: a Propensity Score-Matched Analysis

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts

Suchergebnisse filtern